You are here

  • Home
  • Online First
  • Outcomes in patients requiring intensive care for CAR T-cell toxicity

Article Text

Article menu

other Versions

Download PDFPDF
DTB select
Outcomes in patients requiring intensive care for CAR T-cell toxicity

Abstract

Overview of: Azoulay É, Castro P, Maamar A, et al. Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study. Lancet Haematol. 2021;8:e355–64.

  • health care quality
  • access
  • and evaluation
  • drug-related side effects and adverse reactions

https://doi.org/10.1136/dtb.2021.000056

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; internally peer reviewed.